Skip to main content
. 2010 Sep;161(3):518–526. doi: 10.1111/j.1365-2249.2010.04195.x

Fig. 2.

Fig. 2

Steady-state plasma total immunoglobulin G (IgG) concentration-versus-time curves during intravenous or subcutaneous administration of immune globulin intravenous (human), 10% caprylate/chromatography purified (IGIV-C). Projected total IgG concentrations for subcutaneous IGIV-C (days 7–28) were based on measured concentrations over 0–7 days obtained during week 17 of the subcutaneous phase. Data are reported for the pharmacokinetic population and as mean ± standard error.